Insider screener

Period: 12 months Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,047 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,047 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,047 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,047 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,047 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,047 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,047 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
12 Feb 2026
Jason M Bunge Chief Marketing Officer
Sold at will
$252.34K 2,380 at 106.03
6.4%
Not planned
12 Feb 2026
Christopher B. Dial SVP, GC and Secretary
Sold at will
$248.98K 5,879 at 42.35
3.1%
Not planned
12 Feb 2026
Paula Tuffin General Counsel and CCO
Sold on a plan 2×
$229.88K 8,018 at 28.67
15.9%
Planned (10b5-1)
12 Feb 2026
Philip Austin Singleton Jr. Executive Chairman · indirect
Bought
$225.46K 18,008 at 12.52
2.4%
12 Feb 2026
John Z Zhang Exec. Vice President & CCDO
Sold at will
$204.76K 1,531 at 133.75
100%
Sold half or more
12 Feb 2026
David Malcom Rodman Chief Medical Officer
Sold on a plan 2×
$184.08K 6,349 at 28.99
11.2%
Planned (10b5-1)
12 Feb 2026
Patrick John Finn President and COO
Sold on a plan
$175.79K 3,500 at 50.23
1.1%
Planned (10b5-1)
12 Feb 2026
David A. Beitel Chief Technology Officer
Sold at will
$175.38K 3,966 at 44.22
2.8%
Not planned
12 Feb 2026
Dan Spaulding Chief People Officer
Sold on a plan
$172.39K 3,901 at 44.19
7.7%
Planned (10b5-1)
12 Feb 2026
Clive Bellows Co-President Asset Servicing
Sold at will
$166.76K 1,148 at 145.26
3.3%
Not planned
12 Feb 2026
Guy Gibson Co-President Asset Servicing
Sold at will
$153.77K 1,043 at 147.43
2.9%
Not planned
12 Feb 2026
Dorchester Minerals Operating LP Entity Under Common Control
Bought on a plan
$125.40K 5,000 at 25.08
11.1%
Bought on a plan
12 Feb 2026
Andrew Benjamin Walz President, DM&C
Sold at will
$122.14K 666 at 183.40
31.3%
Not planned
12 Feb 2026
Donald Notman Chief Operating Officer
Sold at will
$103.47K 11,446 at 9.04
3.0%
Not planned
12 Feb 2026
Arun Rajan Chief Strat & Innov Officer
Bought
$101.10K 605 at 167.11
0.5%
First buy on file
12 Feb 2026
Bought
$100.00K 594 at 168.24
1.7%
First buy on file
12 Feb 2026
Sang Yi Group President, Asia Pacific
Sold at will
$96.49K 1,000 at 96.49
5.4%
Not planned
12 Feb 2026
Corey Neil Riley CIO & CCO
Sold on a plan
$95.94K 3,500 at 27.41
2.2%
Planned (10b5-1)
12 Feb 2026
Jennifer Rock Chief Accounting Officer
Sold at will
$95.70K 2,164 at 44.22
5.3%
Not planned
12 Feb 2026
Lynne J Caljouw EVP, Chief HR Officer
Sold at will
$93.67K 2,496 at 37.53
3.8%
Not planned
12 Feb 2026
Sanjay Nayak Chief Strategy Officer
Sold on a plan
$93.55K 10,348 at 9.04
3.0%
Planned (10b5-1)
12 Feb 2026
Jun Choo Chief Operating Officer
Sold at will
$91.16K 2,061 at 44.23
1.9%
Not planned
12 Feb 2026
Bradley D. Owens General Counsel
Sold on a plan
$89.16K 2,017 at 44.20
5.3%
Planned (10b5-1)
12 Feb 2026
Susan E Krohne Chief Legal Officer, Secretary
Sold at will
$72.08K 491 at 146.80
5.3%
Not planned
12 Feb 2026
Nadia Waheed Chief Medical Officer
Sold on a plan
$71.08K 7,863 at 9.04
2.4%
Planned (10b5-1)
12 Feb 2026
Jay David Youngblood SVP, Chief Digital Officer
Sold at will
$65.41K 987 at 66.27
12.9%
Not planned
12 Feb 2026
Badri N Dasu Chief Engineering Officer also filed by Shakil Aslam
Bought
$28.43K 35,000 at 0.81
84.9%
First buy on file
12 Feb 2026
Jonathan C Meltzer EVP, Operations
Sold on a plan
$25.27K 87 at 290.42
3.0%
Planned (10b5-1)
12 Feb 2026
William Andrew Macan EVP, CLO and CS
Sold at will
$23.30K 14,120 at 1.65
2.1%
Not planned
12 Feb 2026
Ann Marie Hunker Principal Accounting Officer
Sold at will
$19.38K 132 at 146.80
3.7%
Not planned
12 Feb 2026
Brian K. Walz VP & Treasurer
Sold on a plan
$14.00K 200 at 70.00
0.9%
Planned (10b5-1)
12 Feb 2026
Steven P. Pryzbyla CLO and Secretary
Sold at will
$10.22K 3,000 at 3.41
0.8%
Not planned
12 Feb 2026
Thomas Charles Heineman Chief Medical Officer
Bought
$10.03K 12,132 at 0.83
4.5%
First buy on file
12 Feb 2026
Allison Hagerman VP, Product Development
Bought
$8.30K 10,000 at 0.83
9.5%
First buy on file
12 Feb 2026
Michelle L Gullo Senior Vice President & CHRO · indirect
Sold at will
$5.98K 44 at 135.83
100%
Sold half or more
12 Feb 2026
Jennifer Michaelson Chief Scientific Officer
Sold at will
$5.00K 416 at 12.03
0.3%
Not planned
12 Feb 2026
Mitchell Lawrence Jones Chief Medical Officer
Sold at will
$3.48K 1,989 at 1.75
13.0%
Not planned
12 Feb 2026
Murray Stahl President/Co-Portfolio Manager · indirect
Bought 6×
$2.11K 774 at 2.73
0.2%
12 Feb 2026
Murray Stahl President/Co-Portfolio Manager
Bought
$982.80 360 at 2.73
0.2%
12 Feb 2026
Nicole Murphy Head of Pharm Ops and Tech
Bought
$585.11 3 at 195.04
0.0%
First buy on file
11 Feb 2026
John F.w. Rogers Executive Vice President
Sold at will 18×
$12.61M 13,151 at 959.03
25.2%
Not planned
11 Feb 2026
Richard C Adkerson Chairman of the Board
Sold at will 2×
$9.89M 152,960 at 64.65
4.4%
Not planned
11 Feb 2026
Lange Bob De Group President
Sold at will
$9.59M 12,507 at 767.08
12.8%
Not planned
11 Feb 2026
Robert L. Goldstein Chief Operating Officer
Sold at will 4×
$5.74M 5,293 at 1,084.22
10.3%
Not planned
11 Feb 2026
Alexis Le-Quoc Chief Technology Officer
Sold on a plan 7×
$5.47M 43,106 at 126.79
8.1%
Planned (10b5-1)
11 Feb 2026
Douglas N. Currault II EVP & General Counsel
Sold at will
$4.84M 75,000 at 64.52
25.5%
Not planned
11 Feb 2026
Andrew D Ross President & COO
Sold at will 10×
$4.66M 4,664 at 999.00
26.2%
Not planned
11 Feb 2026
Maamoun Rajeh President, Arch Capital Group
Sold at will
$4.56M 47,430 at 96.12
9.9%
Not planned
11 Feb 2026
Forrest Eugene Norrod EVP & Gm Desg
Sold on a plan 4×
$4.22M 19,450 at 216.81
6.3%
Planned (10b5-1)
Showing 17,301–17,350 of 23,047. ← Newer Page 347 of 461 Older →